Bipolar Androgen Therapy (BAT) and Radium-223 (RAD) in Metastatic Castration-resistant Prostate Cancer (mCRPC)

Clinical trial NCT04704505 · RECRUITING

Trial details

NCT number: NCT04704505
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Adenocarcinoma Metastatic Prostate Adenocarcinoma Castration-resistant

Start date: 2022-04-28
Primary completion: 2028-02-01
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.